Medcamp S.A.

WSE:MDP Stock Report

Market Cap: zł11.2m

Medcamp Past Earnings Performance

Past criteria checks 3/6

Medcamp has been growing earnings at an average annual rate of 44.7%, while the Real Estate industry saw earnings growing at 9.5% annually. Revenues have been declining at an average rate of 27.1% per year.

Key information

44.7%

Earnings growth rate

44.7%

EPS growth rate

Real Estate Industry Growth6.5%
Revenue growth rate-27.1%
Return on equity25.4%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medcamp makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

WSE:MDP Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240100
31 Mar 240-100
31 Dec 230-200
30 Sep 230-600
30 Jun 230-600
31 Mar 230-610
31 Dec 220-610
30 Sep 220-510
30 Jun 220-410
31 Mar 220-800
31 Dec 210-210
30 Sep 210-210
30 Jun 210-100
31 Mar 210700
31 Dec 200400
30 Sep 200-500
30 Jun 200-2000
31 Mar 200-3300
31 Dec 190-3600
30 Sep 190-2310
30 Jun 190-1110
31 Mar 190-310
31 Dec 184-110
30 Sep 184000
30 Jun 184000
31 Mar 184100
31 Dec 170000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160-100
31 Mar 160-100
31 Dec 150000
31 Dec 141010
31 Dec 131010

Quality Earnings: MDP has a high level of non-cash earnings.

Growing Profit Margin: MDP became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MDP has become profitable over the past 5 years, growing earnings by 44.7% per year.

Accelerating Growth: MDP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: MDP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Real Estate industry (1.1%).

Return on Equity

High ROE: MDP's Return on Equity (25.4%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 13:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medcamp S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution